Separate and combined blockades of α- and β-adrenergic receptors in forearm sweating induced by adrenergic agents and exercise in the heat in young adults

Am J Physiol Regul Integr Comp Physiol. 2025 Feb 1;328(2):R181-R194. doi: 10.1152/ajpregu.00120.2024. Epub 2024 Dec 20.

Abstract

The assessment of adrenergic modulation of sweating as assessed via pharmacologic administration of α- and β-adrenergic receptor blockers during exercise has yielded mixed findings. However, the underlying mechanisms for this disparity remain unresolved. We investigated the effects of separate and combined blockade of α- and β-adrenergic receptors on forearm sweating induced by a 30-min moderate-intensity exercise bout (n = 17, protocol 1) and the administration of adrenergic agonists epinephrine and norepinephrine (n = 16, protocol 2) in the heat. Adrenergic receptor blockade was induced via the separate and combined iontophoretic administration of terazosin (α-adrenergic receptor antagonist) and propranolol (β-adrenergic receptor antagonist) on forearm skin. Bretylium, a noradrenergic sympathetic nerve inhibitor, was also administered separately in protocol 1. In protocol 1, relative to the separate administration of propranolol, terazosin alone or in combination with propranolol attenuated exercise sweating to a similar extent (both P ≤ 0.037), although the effect was reduced relative to that observed with bretylium treatment (P < 0.001). In protocol 2, administration of propranolol increased norepinephrine- (P = 0.029) but not epinephrine-induced sweat rate. The combined administration of terazosin reversed this response, attenuating sweating (P < 0.001) to a greater extent than terazosin treatment alone (P = 0.030). Altogether, we showed that although β-adrenergic receptors may interact with α-adrenergic receptors pharmacologically, it does not appear to modulate exercise-induced sweating on the forearm. Furthermore, α- but not β-adrenergic receptors independently modulate the regulation of forearm sweating during exercise in the heat. Finally, the bretylium-induced reduction in forearm sweat rate during exercise likely occurs independently of α- and β-adrenergic receptors.NEW & NOTEWORTHY Pharmacological stimulation of α- and β-adrenergic receptors produces sweating in vivo. Still, the separate and interactive roles of these adrenergic receptors during exercise and pharmacological adrenergic stimulation in the heat remain unknown. We showed that β-adrenergic receptors may interact with α-adrenergic receptors pharmacologically, but it does not modulate exercise-induced sweating. The α-adrenergic receptors independently modulate sweating during exercise in the heat. We provide important new insights into our understanding of the mechanisms regulating human sweating.

Keywords: adrenaline; adrenoreceptors; catecholamines; eccrine sweat glands; noradrenaline.

MeSH terms

  • Adrenergic alpha-1 Receptor Antagonists / administration & dosage
  • Adrenergic alpha-1 Receptor Antagonists / pharmacology
  • Adrenergic alpha-Antagonists / administration & dosage
  • Adrenergic alpha-Antagonists / pharmacology
  • Adrenergic beta-Antagonists* / administration & dosage
  • Adrenergic beta-Antagonists* / pharmacology
  • Adult
  • Bretylium Tosylate / administration & dosage
  • Bretylium Tosylate / pharmacology
  • Epinephrine / administration & dosage
  • Exercise* / physiology
  • Female
  • Forearm*
  • Hot Temperature*
  • Humans
  • Male
  • Norepinephrine
  • Prazosin* / analogs & derivatives
  • Prazosin* / pharmacology
  • Propranolol* / administration & dosage
  • Propranolol* / pharmacology
  • Receptors, Adrenergic, alpha / drug effects
  • Receptors, Adrenergic, alpha / metabolism
  • Receptors, Adrenergic, beta* / drug effects
  • Receptors, Adrenergic, beta* / metabolism
  • Sweating* / drug effects
  • Young Adult

Substances

  • Adrenergic beta-Antagonists
  • Propranolol
  • Prazosin
  • Terazosin
  • Receptors, Adrenergic, beta
  • Receptors, Adrenergic, alpha
  • Adrenergic alpha-1 Receptor Antagonists
  • Norepinephrine
  • Bretylium Tosylate
  • Epinephrine
  • Adrenergic alpha-Antagonists